TNF and cancer: In fact, several GNP formulations have already entered clinical trials for cancer treatment, including CYT-6091 (27 nm citrate-coated GNPs bound with thiolated PEG and TNFalpha) [41], and AuroShell® particles (∼150 nm, silica core with a gold shell, clinicaltrials.gov identifier # NCT00848042).